These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease. Giffard PM, Tong SYC, Holt DC, Ralph AP, Currie BJ. PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007511. PubMed ID: 31269021 [Abstract] [Full Text] [Related]
5. Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage. Engel ME, Muhamed B, Whitelaw AC, Musvosvi M, Mayosi BM, Dale JB. Pediatr Infect Dis J; 2014 Feb; 33(2):208-10. PubMed ID: 23934204 [Abstract] [Full Text] [Related]
8. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development. Salie T, Engel K, Moloi A, Muhamed B, Dale JB, Engel ME. mSphere; 2020 Jul 15; 5(4):. PubMed ID: 32669471 [Abstract] [Full Text] [Related]
11. The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region. Baroux N, D'Ortenzio E, Amédéo N, Baker C, Ali Alsuwayyid B, Dupont-Rouzeyrol M, O'Connor O, Steer A, Smeesters PR. Clin Infect Dis; 2014 Oct 15; 59(7):e84-92. PubMed ID: 24965347 [Abstract] [Full Text] [Related]
15. Molecular biology of Group A Streptococcus and its implications in vaccine strategies. Brahmadathan NK. Indian J Med Microbiol; 2017 Jun 15; 35(2):176-183. PubMed ID: 28681803 [Abstract] [Full Text] [Related]
19. Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013. Williamson DA, Moreland NJ, Carter P, Upton A, Morgan J, Proft T, Lennon D, Baker MG, Dunbar R, Fraser JD. N Z Med J; 2014 Jan 24; 127(1388):55-60. PubMed ID: 24481387 [Abstract] [Full Text] [Related]